Venture Capital

As AI's energy demands soar, Omni Design's new 200G co-packaged optics IP on a 3nm process promises a leap in data center efficiency and speed.

India's top university is planting its flag in the US, launching a new foundation to accelerate deep-tech startups and forge a transatlantic tech pipeline.

The biotech firm launches clinical-grade solutions at ATW 2026, promising to boost cell therapy quality, consistency, and regulatory alignment.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

The lab automation firm is pivoting to intelligent systems, allowing scientists to create experiments with natural language to accelerate research.

TCL launches its solar-powered 'Edelweiss Land' in Milan, a bold marketing move timed with the Winter Olympics that highlights its green ambitions.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

With a fresh $8.5M in funding and a powerful ally in KYMCO Capital, Sleek EV is accelerating its mission to dominate Southeast Asia's EV market.

With a new industrial leader, Lithium de France is accelerating its ambitious plan to supply one-third of the nation's lithium from geothermal sources.

MGM Resorts moved its earnings date up, and now we know why. The gaming giant beat Wall Street estimates with powerful results from BetMGM and Macau.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

Ex-NFL star Mark Clayton’s headphone brand, LIVV Audio, partners with The Uptown Agency to take on giants like Beats with its athlete-built active gear.

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

Crave lands the exclusive Canadian rights to SATURDAY NIGHT LIVE UK, a bold move to battle streaming giants with a globally recognized comedy franchise.

Ex-Joint Chiefs Vice Chair Admiral Grady joins Domino Data Lab's board, signaling a major push to accelerate AI for U.S. national security missions.

Colombier Acquisition Corp. III, with a board of political and tech heavyweights, has a $299M war chest. Its hunt for a 'patriotic' target begins.